von Tobias Borgers | Jun 21, 2022 | Boehringer
Companies to research Antibody-Drug Conjugates (ADC) to address cancers of high unmet need Collaboration to utilize ImmunoGen’s ADC linker-payload technology directed to targets identified by OBT Each company may select a number of pre-clinical programs for...
von Tobias Borgers | Jun 21, 2022 | Continuous Manufacturing
Sirona Biochem Inc. (TSXV:SBM) is a biotechnology company with an innovative platform for developing safer, more effective cosmetic and pharmaceutical active ingredients. The technology is based on proprietary fluorination chemistry developed by the company’s...
von Tobias Borgers | Jun 21, 2022 | Continuous Manufacturing
Digital transformation is a major undertaking for any manufacturer. But factor in the mission critical, highly regulated, and quality-conscious nature of pharmaceutical production and the effort becomes even more daunting.Pharma 4.0 is a maturity model-based framework...
von Tobias Borgers | Jun 21, 2022 | Continuous Manufacturing
$111 Million Equity Investment Round to Support Continued Development and Deployment of ApiJect’s Proprietary High-Volume Manufacturing Platform for Single-Dose Prefilled Injection Devices. STAMFORD, Conn., May 18, 2022 /PRNewswire/ — ApiJect Holdings,...
von Tobias Borgers | Jun 13, 2022 | Boehringer
Biotechnologie-Branche verbucht Rekorde bei Umsatz und Nach dem Tech-Crash:
Bei diesen Aktien lohnt sich der Einstieg jetzt! FuE-InvestitionenBerlin (ots) – Im Jahr 2021 sind Umsatz und Ausgaben für Forschung undEntwicklung (FuE) der deutschen...
